Andres Juan

About Andres Juan

Juan Andres is a seasoned biopharmaceutical executive recognized for deep expertise in technical operations, quality, and large-scale manufacturing execution. At Moderna, Inc., he served as Chief Technical Operations and Quality Officer before transitioning in 2023 to President, Strategic Partnerships and Enterprise Expansion. His tenure at Moderna coincided with a pivotal period in the company’s evolution, as it moved from a clinical-stage biotech to a commercial organization with global relevance in messenger RNA science. Prior to Moderna, Andres spent a substantial part of his career at Eli Lilly, where he held manufacturing, production, and quality responsibilities over many years. His work took him across the United States, Puerto Rico, the United Kingdom, and Spain, giving him broad international experience in operational excellence and regulated manufacturing environments. He later joined Novartis, where he served as Global Head of Technical Operations, overseeing manufacturing and supply chain activities across the broader organization. That role expanded his leadership scope to include global production systems, quality oversight, and supply continuity. At Moderna, Andres became closely associated with the company’s manufacturing scale-up and supply readiness. As head of technical operations and quality, he was responsible for technical development, quality, and supply across preclinical, clinical, and commercial programs. He played a central role in the industrialization of Moderna’s COVID-19 vaccine platform, helping guide the company through one of the most demanding scale-up efforts in modern biopharma. Moderna publicly credited him with helping lead manufacturing, quality control, and distribution for hundreds of millions of vaccine doses during the pandemic, underscoring the operational complexity and speed required in that period. His leadership profile combines supply chain strategy, quality systems, manufacturing governance, and the ability to translate innovative science into dependable commercial operations. Andres holds a Master’s degree in Pharmacy from the University of Alcalá de Henares in Madrid and completed an advanced development program at London Business School. In 2022, Moderna announced that he had been elected to the National Academy of Engineering, reflecting his recognized contribution to the scale-up and manufacturing of important pharmaceutical products, including the mRNA COVID-19 vaccine.